Enlivex Ltd. (ENLV)
0.68
+0.01
(+1.10%)
USD |
NASDAQ |
Jun 11, 13:35
Enlivex Total Assets (Quarterly) : 2.327B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.327B |
| September 30, 2025 | 20.94M |
| June 30, 2025 | 22.60M |
| March 31, 2025 | 24.04M |
| December 31, 2024 | 27.69M |
| September 30, 2024 | 29.80M |
| June 30, 2024 | 31.90M |
| March 31, 2024 | 31.05M |
| December 31, 2023 | 36.83M |
| September 30, 2023 | 46.94M |
| June 30, 2023 | 53.03M |
| March 31, 2023 | 60.02M |
| December 31, 2022 | 67.64M |
| September 30, 2022 | 72.41M |
| June 30, 2022 | 77.34M |
| March 31, 2022 | 88.62M |
| December 31, 2021 | 95.15M |
| September 30, 2021 | 98.17M |
| June 30, 2021 | 95.19M |
| March 31, 2021 | 95.96M |
| December 31, 2020 | 40.36M |
| September 30, 2020 | 33.37M |
| June 30, 2020 | 35.44M |
| March 31, 2020 | 37.65M |
| December 31, 2019 | 17.56M |
| Date | Value |
|---|---|
| September 30, 2019 | 19.22M |
| June 30, 2019 | 20.83M |
| March 31, 2019 | 19.05M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 3.622M |
| September 30, 2017 | 4.283M |
| June 30, 2017 | 5.514M |
| March 31, 2017 | 7.886M |
| December 31, 2016 | 10.63M |
| September 30, 2016 | 13.37M |
| June 30, 2016 | 16.96M |
| March 31, 2016 | 22.48M |
| December 31, 2015 | 20.52M |
| September 30, 2015 | 23.92M |
| June 30, 2015 | 26.90M |
| March 31, 2015 | 29.85M |
| December 31, 2014 | 32.95M |
| September 30, 2014 | 34.54M |
| June 30, 2014 | 4.516M |
| March 31, 2014 | |
| December 31, 2013 | 0.306M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovelStem International Corp. | 0.1009M |
| Brainstorm Cell Therapeutics, Inc. | 0.755M |
| Summit Therapeutics, Inc. | 647.86M |
| PeptiDream Inc. | 469.52M |
| Kezar Life Sciences, Inc. | 68.00M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 392.05M |
| Shareholders Equity (Quarterly) | 1.935B |
| Debt to Equity Ratio | 0.0003 |
| Current Ratio | 193.24 |
| Net Debt Paydown Yield | 0.01% |